In light of the obtained results, our hypothesis posits that daily oral supplementation with EOCF, even in the absence of insulin administration for DM1, may instigate metabolic regulations leading to a moderation of blood glucose levels, the control of systemic inflammatory activity, and regulation of immune cell recruitment, all of which are consequences of uncontrolled diabetes. The gene discussed is INS; the disease is diabetes mellitus.